J2430
J2430 – Injection, pamidronate disodium, per 30 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 6 NDCs crosswalked per 30 MG $12.025/unit ASP+6%
📋 J2430 summary
J2430 is a HCPCS Level II J-code used to bill pamidronate disodium, per 30 mg, billed per 30 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Code J2430
Billing unit 30 MG Payment limit $12.025/unit NDC-Crosswalk 6
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2430
DescriptorInjection, pamidronate disodium, per 30 mg
Billing unit30 MG
Payment limit / unit$12.025
Est. ASP / unit$11.344 est.
Mapped NDCs6
Data periodQ3 2026
Last updated2026-08-20
💊 About Pamidronate Injection DRUG GUIDE
Pamidronate Disodium Injection is used to treat hypercalcemia of malignancy (dangerously high blood calcium caused by cancer), given alongside adequate fluid hydration.
It is also approved for moderate to severe Paget's disease of bone, a condition where bones break down and rebuild abnormally.In addition, Pamidronate Disodium Injection is used together with standard cancer treatment for osteolytic bone metastases of breast cancer (bone damage caused by breast cancer spreading to bone) and for osteolytic lesions of multiple myeloma (bone damage from this blood cancer).
Clinical overview from our editorial drug guide for Pamidronate Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$12.025
Est. ASP / unit
$11.344 est.
Est. after 2% sequester
$11.785
HCPCS dosage
30 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, pamidronate disodium, per 30 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2430 = 30 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2430 WITH EST. MEDICARE PAY
6 NDCs map to J2430. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($12.025/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 61703-0324-18 | Pamidronate Disodium 3 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-324... | 3 mg/mL | 1 | $12.03 | — | ● Active | CMS + PDAC |
| 61703-0325-18 | Pamidronate Disodium 6 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-325... | 6 mg/mL | 2 | $24.05 | — | ● Active | CMS + PDAC |
| 61703-0326-18 | Pamidronate Disodium 9 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-326... | 9 mg/mL | 3 | $36.08 | — | ● Active | CMS + PDAC |
| 67457-0430-10 | Pamidronate Disodium 3 mg/mL INJECTION | Mylan | 1 VIAL in 1 CARTON (67457-430-10) / 10 mL... | 3 mg/mL | 1 | $12.03 | — | ● Active | CMS ASP |
| 67457-0446-10 | Pamidronate Disodium 9 mg/mL INJECTION | Mylan | 1 VIAL in 1 CARTON (67457-446-10) / 10 mL... | 9 mg/mL | 3 | $36.08 | — | ● Active | CMS ASP |
| 00703-4085-51 | PAMIDRONATE DISODIUM 9 MG/ML | Unknown | — | — | 0.3 | $3.61 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$3K
Claims
118
Beneficiaries
80
Spend / beneficiary
$37.69
Spend / claim
$25.55
Trend by period
Where J2430 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #731 of 824
#726
ENGERIX-B PEDIATRIC-... 90744
$3.2K
#727
TESTOSTERONE ENANTHA... J3121
$3.1K
#728
DOPAMINE HCL IN 5% D... J1265
$3.1K
#729
HALDOL DECANOATE 100... J1631
$3.1K
#730
GEMCITABINE HCL(J919... J9196
$3K
#731
PAMIDRONATE DISODIUM J2430
$3K
#732
LEVOFLOXACIN-D5W J1956
$2.9K
#733
CLEOCIN PHOSPHATE* J0736
$2.8K
#734
MANNITOL(J2151) J2151
$2.8K
#735
CHLOROTHIAZIDE SODIU... J1205
$2.7K
#736
AZMIRO J1072
$2.7K
Total claims — #612 of 824
#607
EPYSQLI Q5151
124
#608
CEFTAROLINE FOSAMIL* J0712
122
#609
ELOCTATE J7205
122
#610
AZITHROMYCIN* J0456
121
#611
MATRION 1 SQ CM** Q4201
121
#612
PAMIDRONATE DISODIUM J2430
118
#613
REEVA, PER SQ CM** Q4314
118
#614
PROTAMINE SULFATE J2720
116
#615
PREDNISOLONE SODIUM... J7510
116
#616
IFEX* J9208
115
#617
NOVOSEVEN RT J7189
114
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $3K | 80 | 118 | $37.69 | $25.55 |
| 2025 (Q1-Q4) | $19.4K | 235 | 695 | $82.42 | $27.87 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$17.2K
Medicare paid
$14.8K
Submitted services
1,478
Denial rate
0.8%
Allowed / service
$11.73
Submitted charges
$296.9K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J2430
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
6 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2430 billing FAQ
What is HCPCS code J2430?
J2430 is a HCPCS Level II J-code used to bill Injection, pamidronate disodium, per 30 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2430?
One unit of J2430 represents 30 MG. Report the number of units equal to the dose administered divided by 30 MG.
How many units of J2430 should I bill?
Divide the dose administered by the code's unit size (30 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2430?
The Medicare Part B payment limit is $12.025 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $11.785 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2430?
6 NDCs currently map to J2430 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2430 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.